Maud Marques

1.2k citations
26 papers · 914 indexed · h-index 17
    • RNA modifications and cancer 6
    • Genomics and Chromatin Dynamics 5
    • Epigenetics and DNA Methylation 4
    • RNA and protein synthesis mechanisms 3
    • PARP inhibition in cancer therapy 5
    • Colorectal Cancer Treatments and Studies 3
    • Cancer Genomics and Diagnostics 5
    • Ovarian cancer diagnosis and treatment 3
  • Pharmacology top 10%

Maud Marques

23 papers receiving 908 citations

Peers

Maud Marques
Comparison fields: 5 of 98
  • Molecular Biology 647
  • Oncology 202
  • Cancer Research 108
  • Reproductive Medicine 47
  • Pharmacology 48
Replace A‐Mei Huang with:
A‐Mei Huang Taiwan
Xiaojia Guo United States
Surojeet Sengupta United States
Kestutis Planutis United States
Nataša Debeljak Slovenia
Ramadevi Subramani United States
Simona Piaggi Italy
Martin S. Hoagland United States
Ercan Çaçan Türkiye
Maud Marques relative to A‐Mei Huang Taiwan A‐Mei Huang's profile →
Citations per field
00.5×1.7×
A‐Mei Huang · 1×
Citations per year

Countries citing papers authored by Maud Marques

Since Specialization
Citations

This map shows the geographic impact of Maud Marques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maud Marques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maud Marques more than expected).

Fields of papers citing papers by Maud Marques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maud Marques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maud Marques. The network helps show where Maud Marques may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maud Marques, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maud Marques Line = papers co-authored together Maud Marques links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20230
3 20230
4 20202
5 201952
6 201920
7 201825
8 201759
9 201781
10 201624
11 2016149
12 201637
13 201575
14 201516
15 20143
16 201437
17 201425
18 201367
19 201018
20 201081

About Maud Marques

Maud Marques is a scholar working on Cancer Research, Oncology and Reproductive Medicine, having authored 26 papers that have together received 914 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), PARP inhibition in cancer therapy (5 papers), Genomics and Chromatin Dynamics (5 papers), Epigenetics and DNA Methylation (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Molecular Biology (647 citations), Oncology (202 citations) and Cancer Research (108 citations). Maud Marques has collaborated with scholars based in Canada, United States and Brazil. Frequent co-authors include Michael Witcher, Luc Gaudreau, Liette Laflamme, Khalid Hilmi, Tatiana Shorstova, Tiejun Zhao, Alain Gervais, Qiang Sun, Moulay A. Alaoui‐Jamali and Amine Saad. Their work appears in journals such as Nucleic Acids Research, BMC Cancer, International Journal of Molecular Sciences, Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026